| Tretinoin | Approved Investigational Nutraceutical | LCE3B | 353143 |
downregulated | Tretinoin results in decreased expression of LCE3B mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LCK | 3932 |
upregulated | Tretinoin results in increased expression of LCK mRNA | 1p35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LCN2 | 3934 |
upregulated | Tretinoin metabolite results in increased expression of LCN2 mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | LCN2 | 3934 |
upregulated | Tretinoin results in increased expression of LCN2 mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | LCP2 | 3937 |
upregulated | Tretinoin results in increased expression of LCP2 mRNA | 5q35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LCTL | 197021 |
downregulated | Tretinoin results in decreased expression of LCTL mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | LDHA | 3939 |
downregulated | Tretinoin results in decreased expression of LDHA mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LDHC | 3948 |
downregulated | Tretinoin results in decreased expression of LDHC mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LDLR | 3949 |
upregulated | Tretinoin results in increased expression of LDLR mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LDLRAD3 | 143458 |
downregulated | Tretinoin results in decreased expression of LDLRAD3 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | LDLRAD4 | 753 |
downregulated | Tretinoin results in decreased expression of LDLRAD4 mRNA | 18p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | LFNG | 3955 |
downregulated | Tretinoin results in decreased expression of LFNG mRNA | 7p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS1 | 3956 |
downregulated | Tretinoin results in decreased expression of LGALS1 mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS1 | 3956 |
upregulated | Tretinoin results in increased expression of LGALS1 mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS3 | 3958 |
downregulated | Tretinoin results in decreased expression of LGALS3 mRNA | 14q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS3 | 3958 |
upregulated | Tretinoin results in increased expression of LGALS3 mRNA | 14q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS3BP | 3959 |
upregulated | Tretinoin results in increased expression of LGALS3BP mRNA | 17q25 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS8 | 3964 |
upregulated | Tretinoin results in increased expression of LGALS8 mRNA | 1q43 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS9 | 3965 |
upregulated | Tretinoin results in increased expression of LGALS9 mRNA | 17q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LGALS9C | 654346 |
upregulated | Tretinoin results in increased expression of LGALS9C mRNA | 17p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LGI1 | 9211 |
downregulated | Tretinoin results in decreased expression of LGI1 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | LGI1 | 9211 |
upregulated | Tretinoin results in increased expression of LGI1 mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | LHFPL2 | 10184 |
upregulated | Tretinoin results in increased expression of LHFPL2 mRNA | 5q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LHX1 | 3975 |
upregulated | Tretinoin results in increased expression of LHX1 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | LHX2 | 9355 |
downregulated | Tretinoin results in decreased expression of LHX2 mRNA | 9q33.3 | |